Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience.

@article{Wang2010RetrospectiveSO,
  title={Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience.},
  author={Hong Wang and Liangchun Hao and Xiuli Wang and Jiate Li and Qiong Wu and Shuang Bian},
  journal={International journal of hematology},
  year={2010},
  volume={91 5},
  pages={820-5}
}
There are very limited reports about childhood acute promyelocytic leukemia (APL), especially about arsenic trioxide (ATO) treatment in both induction and post-remission regimens. 35 newly diagnosed APL patients received ATO treatment in our center and the clinical course as well as the outcome of them was investigated. The dose of intravenous ATO was 0.15-0.17 mg/kg per day, only one patient got 0.33 mg/kg per day, maximum dose was 10 mg per day in induction therapy with minimal chemotherapy… CONTINUE READING

Similar Papers

Loading similar papers…